Repository logo
 

Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.

Accepted version
Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/292422

Repository DOI

https://doi.org/10.17863/CAM.39579
Thumbnail Image

Files

Accepted version (408.26 KB)
 Supporting information (572.58 KB)

Type

Article

Change log

Authors

Description

Keywords

essential thrombocythaemia, megakaryocytopoiesis, microvesicles, myelofibrosis, platelet activation, ruxolitinib, Blood Platelets, Female, Humans, Janus Kinases, Male, Megakaryocytes, Nitriles, Primary Myelofibrosis, Pyrazoles, Pyrimidines

Journal Title

Br J Haematol

Conference Name

Journal ISSN

0007-1048
1365-2141

Volume Title

185

Publisher

Wiley

Publisher DOI

https://doi.org/10.1111/bjh.15682

Rights and licensing

All rights reserved
Except where otherwised noted, this item's license is described as All rights reserved
Sponsorship
Italian Association for Cancer Research (AIRC) (Fellowship Rif. 20930)
Medical Research Council (MC_PC_12009)

Collections

University of Cambridge Research Outputs (Articles and Conferences)